'On standalone basis
Quarter ended September 2024 compared with Quarter ended September 2023.
Net sales (including other operating income) of Abbott India has increased 9.27% to Rs 1,632.67 crore. Operating profit margin has jumped from 25.49% to 26.89%, leading to 15.25% rise in operating profit to Rs 438.96 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 9.61% to 10.48%. Purchase of finished goods cost rose from 43.82% to 44.99%. Employee cost decreased from 9.78% to 8.98%. Other expenses fell from 10.70% to 8.81%.
Other income up 8.95% to Rs 60.48 crore. PBIDT rose 14.45% to Rs 499.44 crore. Provision for interest fell 20.13% to Rs 2.5 crore. Loan funds declined from Rs 91.54 crore as of 30 September 2023 to Rs 60.50 crore as of 30 September 2024. Inventories rose to Rs 739.14 crore as of 30 Septe...
Pleaselogin & subscribe to view the full report.
More Reports
|
|